Randomization Is Not Just About Balance - It Provides the foundation for Valid Causal Inference

Randomization in clinical trials is often perceived as a tool to "balance covariates" between treatment groups. While correct, this explanation is incomplete and somewhat misleading. Randomization is not primarily about balance. It provides a design-based foundation for valid causal inference.

1. Where does the probability come from?

In a randomized clinical trial, probability is not introduced through modeling assumptions such as normality, nor is it fundamentally about sampling from a target population. Instead, probability is introduced solely by design. Consider the potential outcomes framework. For each subject 𝑖, let

• 𝑌ᵢ (1): outcome under treatment

• 𝑌ᵢ (0): outcome under control

Under the null hypothesis of no treatment effect: 𝑌ᵢ (1) = 𝑌ᵢ (0), ∀𝑖. In this framework, the outcomes are fixed (finite population view), and the only source of randomness is treatment assignment. This implies that the null distribution of any test statistic is induced entirely by the randomization mechanism.

2. Randomization creates the reference distribution.

Because treatment assignment is randomized, we can construct a randomization distribution:

• Enumerate (or approximate) all possible treatment assignments consistent with the design

• Compute the test statistic for each assignment

• Compute the observed statistic to this distribution

This yields exact, finite-sample inference:

• No distributional assumptions

• No large-sample approximations

• No reliance on variance estimation

This is the foundation of Fisher's randomization test and permutation-based inference in randomized experiments. In other words, we do not need to assume a bell-shaped curve or any statistical model.

3. Classical statistical tests are only approximations

Procedures such as t-tests, Wald tests and log-rank tests are often presented as the basis for inference. In randomized clinical trials, these tests can be viewed as large-sample approximations to the underlying randomization-based framework (inference). Their validity ultimately traces back to the randomization mechanism - not to assumptions such as normality or proportional hazards.

4. Balance is a consequence, not the goal of randomization

Randomization is often motivated by its ability to balance covariates. This is, at best, a secondary consequence.

• Balance holds in expectation, not in every realized sample.

• Chance imbalances are inevitable in finite samples.

• These imbalances do not invalidate the statistical analysis.

Covariate adjustment (e.g., ANCOVA) is therefore not required for validity but primarily used to improve statistical efficiency.

5. Protection against the unknown

A central strength of randomization is that it protects against unmeasured confounders and model misspecifications. Statistical adjustment can only address what is measured and correctly modeled, while randomization requires neither. In other words, you can only adjust for what you know and measure. Randomization protects you from what you don't know.

6. Randomization vs modeling

It's important to understand two different paradigms: randomized trials vs observational studies.

Randomized trials

• Inference justified by design

• Minimum assumptions

• Robust to model misspecification

Observational studies

• Inference justified by assumptions

• Requires no unmeasured confounding

• Sensitive to model specifications

Statistical models are optional in randomized trials but indispensable in observational studies.

7. Randomization creates the mechanism for hypothesis testing

Randomization does more than reducing bias - it creates the mechanism for hypothesis testing. Under the null hypothesis, outcomes are fixed and the test statistic varies only through treatment assignment. This provides a well-defined reference distribution for p-values and confidence intervals. Without randomization, such a distribution is not available without additional assumptions. Randomization gives us a principled way to judge whether the observed effect could plausibly arise by chance.

8. Practical considerations

In practice, randomization is often implemented with additional structure such as blocking and/or stratification. These approaches improve finite-sample balance and therefore increase statistical efficiency. However, they do not change the fundamental role of randomization.

9. Regulatory perspectives

Regulatory agencies such as the FDA and EMA place strong emphasis on randomized evidence. This reflects the fact that:

• Causal interpretation is design-based.

• Assumptions are minimized.

• Results are more robust and reproducible.

  
  

In conclusion, the fundamental role of randomization is to create the basis for valid causal inference.